05 July 2021
Today, Monday 5 July 2021, Healthcare at Home has announced a major rebranding exercise, including changing its name to Sciensus. The new name reflects the company’s forward-thinking approach, which aims to harness new digital technology and patient insight to provide patients with more knowledge, more choice and greater convenience.
With a workforce of over 1,700, including more than 500 clinicians across the UK, Healthcare at Home supports in excess of 200,000 patients every year across 49 therapy areas and 450 chemotherapy regimes.
Established in 1992, they have worked in partnership with the NHS, private medical providers and pharmaceutical companies to bring patients the life-changing treatment they need, in the comfort and convenience of their own homes. The new Sciensus vision is to become a global leader in supporting each and every patient to make the most of their medicine – helping people do better, feel better and get better results, long term.
The business has evolved from a home healthcare provider into a leading Pharma Services Company offering four primary lines of service:
- Complex Pharmacy Services, serving the medication needs of over 200,000 chronically ill patients in their home
- End to end solutions for Biotech companies seeking access to the fast-growing European Rare Disease market
- Privately funded home cancer treatment, from inhouse aseptic compounding to chemotherapy nursing
- Early supported discharge service, allowing patients to return home more quickly.
Using valuable insights Sciensus will be helping patients take more control of their health and their personal goals. It will be easier to get support from specialist nurses, therapists and clinicians, easier to manage visits and deliveries, and easier to find helpful, practical information any time patients choose.
Later this year, Sciensus will be launching a new range of secure, user-friendly digital tools, designed in collaboration with patients, to provide more opportunities for them to take control of their medication, understand more about their treatment and condition, and connect with other patients and online support communities.
Richard Blyth, Chief Customer Officer, says: “We’re proud to be evolving our company and building a stronger, more supported future for patients all over the UK and Europe. We’ll still be the same friendly, caring and highly trained team that patients have come to rely on, but we’re making some exciting changes to help us better connect with them in intuitive new ways, every day. By providing things like virtual patient consultations, secure access to patient communities, medication reminders and quick, easy access to information on their condition, we will offer patients greater knowledge, choice, convenience and connection than ever before.”
For any enquiries from the media, please contact: firstname.lastname@example.org
Healthcare is changing and at Sciensus, we’re leading the way. In partnership with the NHS, private providers and pharmaceutical companies, we already deliver specialist care and medication to over 200,000 patients with diverse needs every year. But we’re becoming so much more.
Drawing on unparalleled insight and learning developed over three decades of clinical care, we are developing innovative tools that will help us learn more from every interaction. We are focusing everything we do on the unique needs of each patient. Intuitive new technology will help us understand, learn and tailor the practical, emotional and clinical support patients need and place this right at their fingertips. We’re engaging with them to directly help them get more from their medicine. And we’re empowering them to take control of their health, achieving better outcomes, long term.